Dual asparagine-depriving nanoparticles against solid tumors
Abstract Depletion of circulatory asparagine (Asn) by L-asparaginase (ASNase) has been used for clinical treatment of leukemia, whereas solid tumors are unresponsive to this therapy owing to their active Asn biosynthesis. Herein, we develop a type of core-shell structured cascade-responsive nanopart...
Saved in:
| Main Authors: | Yubo Shen, Huifang Wang, Daoxia Guo, Jiantao Liu, Jinli Sun, Nan Chen, Haiyun Song, Xiaoyuan Ji |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-025-60798-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EVALUATION OF TOXICITY OF INFUSION SOLUTION OF POTASSIUM AND MAGNESIUM ASPARAGINATE 500 ML IN EXPERIMENT
by: A. G. Yushkov, et al.
Published: (2012-07-01) -
CCT196969 inhibits TNBC by targeting the HDAC5/RXRA/ASNS axis to down-regulate asparagine synthesis
by: Qiong Yuan, et al.
Published: (2025-08-01) -
Asparagine synthetase modulates glutaminase inhibitor sensitivity through metabolic reprogramming and serves as a prognostic biomarker in hepatocellular carcinoma
by: Benjian Gao, et al.
Published: (2025-10-01) -
Three Asparagine insertions in the K13-propeller led to Plasmodium falciparum becoming resistant to multiple antimalarial drugs
by: Zheng Xiang, et al.
Published: (2025-08-01) -
3D variability analysis reveals a hidden conformational change controlling ammonia transport in human asparagine synthetase
by: Adriana Coricello, et al.
Published: (2024-12-01)